Flow cytometry analysis revealed that CD8+ T cells in the spleens of TE10 tumor-bearing hu-PBMC-NOG-dKO mice increased significantly following 14 days of AZD4547 treatment at 10 mg/kg (Figure 3B). This evidence concerns the gene CD8A and neoplasm.